GC Biopharma Financial Statements
We are disclosing financial information
To help investors
Make informed decisions.
Unit: KRW million
| Item | 2022 | 2021 | 2020 |
|---|---|---|---|
| Revenue | 1,711,313 | 1,537,826 | 1,504,115 |
| Operating income | 81,264 | 73,662 | 50,253 |
| Net income before taxes | 85,728 | 172,559 | 104,474 |
| Net income | 69,415 | 136,949 | 89,271 |
| Total comprehensive income | 83,596 | 139,328 | 88,059 |
-
- GC MS
- GC Wellbeing
- GCMedis
-
- Overseas
- GC China Pharm
- Curevo
- GC Pharma do Brasil
-
- Foundation
- MOGAM Institue
- GC Labs
- GC i-Med
-
- Others
- GC Invacfarm